- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Vendum Batteries (OTCBB: VNDB), a US-based battery technology development company, is pleased to announce it's making important relationships through attending the UK industry events of NanoTech London and Nano4Energy.
Vendum Batteries met with industry experts, ranging from top scientists, Government agencies interested in assisting in funding prototypes, R&D grant opportunities and important collaboration partners, all focused on the commercialisation of Nano technology.
Fraser Cottington, CEO of Vendum, said, "Through attending the right events, Vendum has been able to develop ever stronger relationships with some of the best industry experts in the UK and Europe. As Government funding policies change, we aim to capitalize on knowing what collaborative grant opportunities exist and how they can become a vital part of our short and long term growth.
"Meeting and selecting industry leaders to work with, remains high on our agenda, we maintain a list of worldwide expos and events we must attend to stay ahead of the competition."
About Vendum Batteries
Vendum Batteries has a pending patent on a non-toxic, carbon-based light-weight battery. The paper-thin battery contains none of the toxic elements used in conventional batteries and its cutting edge carbon nanotube and cellulose-based technology makes it entirely biodegradable. The Vendum Battery will be developed from its current low power capacity, to soon accommodate the ever-increasing global demand for durable battery power for cell phones, iPods, gadgets, human implants and eventually electrical vehicles etc. Americans purchase around 5 billion batteries, leaving 146,000 tons of battery waste behind, and given that the worldwide personal battery use is a growing $63 billion industry, the potential of this revolutionary non-toxic technology could be enormous.
Disclaimer -- Forward Looking Statements
This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements; projected events in this press release may not occur due to unforeseen circumstances, various factors, and other risks identified in a company's annual report on Form 10-K and other filings made by such company.
For more information, please click here
Vendum Batteries Inc.
400 Continental Blvd, 6th floor
El Segundo, CA, 90245
Vendum Batteries Inc.
Accounting Work Suite
400 Thames Valley Park Drive
Vendum Batteries Inc
USA toll free 1(888) 426-1116
NY local 1(646) 224-5914
Copyright © Vendum Batteries, Inc.If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Battery Technology/Capacitors/Generators/Piezoelectrics/Thermoelectrics/Energy storage
X-rays and electrons join forces to map catalytic reactions in real-time: New technique combines electron microscopy and synchrotron X-rays to track chemical reactions under real operating conditions June 29th, 2015
Leti Announces Launch of First European Nanomedicine Characterisation Laboratory: Project Combines Expertise of 9 Partners in 8 Countries to Foster Nanomedicine Innovation and Facilitate Regulatory Approval July 1st, 2015